Sunday, October 30, 2011

Altus Pharma renegotiates Waltham leases - Boston Business Journal:

grachevakautawil.blogspot.com
The Cambridge, Mass.-based companuy said it had effectively ended its leasefor 83,405 square feet of spacw at 333 Wyman St. in Waltham. The leas e is slated to end by Nov. 2 at the latest; the agreemenf can be terminated sooner if Altus is acquired or raises an undiscloseed amountof capital, accordinhg to regulatory filings. Likewise, Altus said it is consolidating its workforce at its facility at 610 Lincolb Streetin Waltham. The company’sd existing, 63,880-square-foot footprint at the site will be reduced by38 percent, or 24,000 square feet. Altus will also receive a correspondinh reduction inrental expenses.
In January, Altuse canceled its program to develop a drug candidate eyed as apotential enzyme-replacemen therapy for pancreatic deficiencies. The companu cut 107 jobs in connection to the Trizytek shutdown and has sincde had a major reshufflinh of its seniorexecutive team.

No comments:

Post a Comment